Seoul Pharma Co. Ltd (018680) — Free Cash Flow Generation Index
Seoul Pharma Co. Ltd (018680) has a Free Cash Flow Generation Index of 0.96x as of June 2025. Free cash flow of ₩1.98 Billion represents 1% of operating cash flow (₩2.07 Billion). Read Seoul Pharma Co. Ltd (018680) total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Seoul Pharma Co. Ltd Free Cash Flow Generation Index (2009–2023)
Historical FCF Generation Index trend for Seoul Pharma Co. Ltd across 8 annual periods. Explore 018680 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Seoul Pharma Co. Ltd (2009–2023)
Year-by-year Free Cash Flow Generation Index for Seoul Pharma Co. Ltd. For the full company profile including market capitalisation, see Seoul Pharma Co. Ltd (018680) total market value.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.64x | ₩3.37 Billion | ₩5.26 Billion | ₩1.89 Billion | ▼ -27.5% |
| 2020 | 0.88x | ₩5.07 Billion | ₩5.74 Billion | ₩671.25 Million | ▼ -16.2% |
| 2019 | 1.05x | ₩3.09 Billion | ₩2.93 Billion | ₩156.43 Million | ▼ -46.9% |
| 2015 | 1.98x | ₩2.82 Billion | ₩1.42 Billion | ₩1.40 Billion | ▼ -28.5% |
| 2014 | 2.77x | ₩4.10 Billion | ₩1.48 Billion | ₩2.62 Billion | ▼ -5.9% |
| 2012 | 2.95x | ₩27.17 Billion | ₩9.22 Billion | ₩17.95 Billion | ▲ +39.1% |
| 2011 | 2.12x | ₩10.29 Billion | ₩4.86 Billion | ₩5.43 Billion | ▼ -64.4% |
| 2009 | 5.95x | ₩7.34 Billion | ₩1.23 Billion | ₩6.11 Billion | — |